FAM171A1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.399530E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.110360E-01
Normal-vs-Stage2
2.397100E-03
Normal-vs-Stage3
1.220400E-01
Normal-vs-Stage4
1.877020E-01
Stage1-vs-Stage2
7.677800E-01
Stage1-vs-Stage3
2.567400E-01
Stage1-vs-Stage4
9.619000E-01
Stage2-vs-Stage3
2.929400E-01
Stage2-vs-Stage4
7.485200E-01
Stage3-vs-Stage4
3.808000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.080940E-03
Normal-vs-AfricanAmerican
1.928760E-01
Normal-vs-Asian
4.975600E-02
Caucasian-vs-AfricanAmerican
6.381900E-02
Caucasian-vs-Asian
5.249800E-01
AfricanAmerican-vs-Asian
3.151600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.376700E-04
Normal-vs-Female
4.358000E-03
Male-vs-Female
1.396430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.959400E-01
Normal-vs-Age(41-60Yrs)
3.556900E-03
Normal-vs-Age(61-80Yrs)
1.858420E-03
Normal-vs-Age(81-100Yrs)
3.959900E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.285800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.530600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.998400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.318400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.081400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.128200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.356400E-03
Normal-vs-Daily Drinker
1.021580E-03
Normal-vs-Weekly Drinker
1.627380E-01
Normal-vs-Occasional Drinker
2.595700E-02
Normal-vs-Social Drinker
1.791710E-02
Non Drinker-vs-Daily Drinker
1.264010E-01
Non Drinker-vs-Weekly Drinker
6.061200E-01
Non Drinker-vs-Occasional Drinker
6.663800E-01
Non Drinker-vs-Social Drinker
5.911000E-01
Daily Drinker-vs-Weekly Drinker
3.545000E-01
Daily Drinker-vs-Occasional Drinker
4.528200E-01
Daily Drinker-vs-Social Drinker
5.011000E-01
Weekly Drinker-vs-Occasional Drinker
9.928000E-01
Weekly Drinker-vs-Social Drinker
9.306600E-01
Occasional Drinker-vs-Social Drinker
9.385200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.867400E-01
Normal-vs-Grade 2
2.393800E-01
Normal-vs-Grade 3
3.208200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.534200E-01
Grade 1-vs-Grade 3
4.973000E-01
Grade 1-vs-Grade 4
2.867400E-01
Grade 2-vs-Grade 3
1.705230E-01
Grade 2-vs-Grade 4
2.393800E-01
Grade 3-vs-Grade 4
3.208200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.879300E-03
Normal-vs-NonDiabetic
1.021380E-03
Diabetic-vs-NonDiabetic
9.334200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.276580E-01
Normal-vs-NoPancreatitis
1.961430E-03
Pancreatitis-vs-NoPancreatitis
1.347160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.542800E-03
Normal-vs-N1
1.521610E-03
N0-vs-N1
4.016800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.419900E-03
Normal-vs-TP53-NonMutant
1.782460E-02
TP53-Mutant-vs-TP53-NonMutant
8.843500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
